US Bancorp’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-41,605
| Closed | -$749K | – | 3947 |
|
|
2020
Q2 | $749K | Sell |
41,605
-5,747
| -12% | -$79.9K | ﹤0.01% | 1092 |
|
|
2020
Q1 | $338K | Buy |
47,352
+844
| +2% | +$10.5K | ﹤0.01% | 1404 |
|
|
2019
Q4 | $1.11M | Sell |
46,508
-90
| -0.2% | -$2.48K | ﹤0.01% | 1013 |
|
|
2019
Q3 | $1.25M | Sell |
46,598
-1,920
| -4% | -$53.9K | ﹤0.01% | 935 |
|
|
2019
Q2 | $1.32M | Buy |
48,518
+199
| +0.4% | +$6.24K | ﹤0.01% | 960 |
|
|
2019
Q1 | $1.68M | Buy |
48,319
+4,185
| +9% | +$121K | ﹤0.01% | 842 |
|
|
2018
Q4 | $862K | Buy |
44,134
+2,530
| +6% | +$52K | ﹤0.01% | 1087 |
|
|
2018
Q3 | $1.11M | Sell |
41,604
-812
| -2% | -$26.5K | ﹤0.01% | 1048 |
|
|
2018
Q2 | $1.6M | Sell |
42,416
-2,203
| -5% | -$84.3K | ﹤0.01% | 894 |
|
|
2018
Q1 | $1.46M | Buy |
44,619
+829
| +2% | +$36.4K | ﹤0.01% | 917 |
|
|
2017
Q4 | $2.13M | Buy |
43,790
+941
| +2% | +$47.6K | 0.01% | 766 |
|
|
2017
Q3 | $2.31M | Buy |
42,849
+1,695
| +4% | +$99.5K | 0.01% | 737 |
|
|
2017
Q2 | $2.31M | Buy |
41,154
+48
| +0.1% | +$1.92K | 0.01% | 710 |
|
|
2017
Q1 | $1.61M | Buy |
41,106
+106
| +0.3% | +$3.38K | 0.01% | 862 |
|
|
2016
Q4 | $920K | Sell |
41,000
-500
| -1% | -$9.77K | ﹤0.01% | 1106 |
|
|
2016
Q3 | $943K | Buy |
41,500
+500
| +1% | +$11.7K | ﹤0.01% | 1055 |
|
|
2016
Q2 | $968K | Hold |
41,000
| – | – | ﹤0.01% | 1023 |
|
|
2016
Q1 | $836K | Hold |
41,000
| – | – | ﹤0.01% | 1073 |
|
|
2015
Q4 | $2.11M | Hold |
41,000
| – | – | 0.01% | 686 |
|
|
2015
Q3 | $1.75M | Buy |
41,000
+20,000
| +95% | +$965K | 0.01% | 741 |
|
|
2015
Q2 | $957K | Buy |
21,000
+11,000
| +110% | +$443K | ﹤0.01% | 1047 |
|
|
2015
Q1 | $380K | Buy |
+10,000
| New | +$343K | ﹤0.01% | 1487 |
|
US Bancorp's PTLA Position: Q3 2020 in Review
US Bancorp sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 41,605 shares — an estimated $749K sold.
US Bancorp first reported a position in PTLA in Q1 2015 and held it in 22 quarters. The position peaked at $2.31M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- US Bancorp reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- US Bancorp sold 41,605 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $749K.
- US Bancorp first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 22 quarters.
- US Bancorp's Portola Pharmaceuticals, Inc. position peaked at $2.31M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on US Bancorp's 13F filing for Q3 2020, filed 10 Nov 2020.